Research Article
Differential Plasma Proteins Identified via iTRAQ-Based Analysis Serve as Diagnostic Markers of Pancreatic Ductal Adenocarcinoma
Table 3
Receiver operating characteristics (ROC) of markers for PDAC.
| | Name | Sensitivity (%) | Specificity (%) | Odds ratio | AUC (95% CI) | Threshold |
| | CA19-9 | 70.0% | 70.0% | 2.33 | 0.750 (0.641-0.859) | >37 U/mL | | AAT | 70.0% | 70.0% | 2.33 | 0.755 (0.650-0.860) | >2933 μg/mL | | RAB2B | 55.0% | 90.0% | 5.50 | 0.712 (0.597-0.827) | >836.9 pg/mL | | IGFBP2 | 52.5% | 85.0% | 3.50 | 0.714 (0.601-0.827) | >7083 pg/mL |
|
|
